CHU-Hôtel Dieu

Nantes 44093

0 studies enrolling now · 10 studies all time

What they study most

Advanced Cancer, Bone Cancer, Carcinoma, Pancreatic Ductal, Colorectal Cancer, Gastric Cancer, Hemophilia A, Hemophilia B, Indolent Systemic Mastocytosis, Infantile Hemangioma, Metastatic Tumours, Moderate to Severe Ulcerative Colitis, Pancreatic Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis — Completed
• A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) — Completed
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed
• Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. — Stopped early
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed
• Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ — Completed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy — Completed